Want to join the conversation?
$NI 2Q15 PR: Expects to deliver non-GAAP net operating EPS of $1.00-1.10 in 2016 with planned infrastructure enhancement investments reaching approx. $1.4Bil. Continues to project long-term earnings and dividend growth of 4-6% annually. On July 2, NI declared a quarterly dividend of $0.155 per share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.